The emergence of vaccines has taken the edge off the worst fears, but a meaningful economic recovery probably remains distant.
0
Tag Archives: Pfizer Inc
Britain Set to Leap Ahead in Approving Vaccines
Regulators may approve the troubled AstraZeneca vaccine and the American-made Pfizer shot weeks before the U.S. does so.
0
The Coronavirus Won’t Stop Evolving When the Vaccine Arrives
The coronavirus is not a shape shifter like the flu virus, but it could become vaccine resistant over time. That prompts researchers to urge vigilance.
0
Military’s Role in Vaccine to Be Strictly Behind the Scenes
While no troops will be administering shots or dropping off doses, scores of Defense Department employees are involved in the effort.
0
Politics, Science and the Remarkable Race for a Coronavirus Vaccine
The furious race to develop a coronavirus vaccine played out against a presidential election, between a pharmaceutical giant and a biotech upstart, with the stakes as high as they could get.
0
Pfizer Applies for Emergency F.D.A. Approval for Covid-19 Vaccine
A large team of regulators at the agency will take about three weeks to review an application spanning thousands of pages.
0
Are Covid-19 Vaccines Really 95% Effective?
You might assume that 95 out of every 100 people vaccinated will be protected from Covid-19. But that’s not how the math works.
0
How the Out-of-Control Pandemic Is Speeding the Hunt for Vaccines
The surge in coronavirus cases worldwide is helping researchers measure more quickly how well their vaccines protect against Covid-19.
0
New Pfizer Results: Coronavirus Vaccine Is Safe and 95% Effective
The company said it planned to apply for emergency approval from the Food and Drug Administration “within days.”
0
The Coronavirus Vaccines Will Likely Work. Making Them Fast Will Be Hard.
Front-runners in the coronavirus vaccine race won’t make nearly as many doses this year as were predicted, but they may kick into high gear next year.
0
States Vow Extra Scrutiny of Coronavirus Vaccine
Special committees, mostly in Democratic states, will seek to reassure the public that an F.D.A.-approved vaccine is safe and effective amid doubts about the Trump administration’s virus response.
0
Coronavirus Vaccine: Early Data Show Moderna’s Version Is 94.5% Effective
Moderna is the second company to report preliminary results from a large trial testing a vaccine. But there are still months to go before it will be widely available to the public.
0
The Coronavirus Pandemic Is Showing Us How Capitalism Is Amazing, and Inadequate
Why big business needs big government and vice versa.
0
How Pfizer Will Distribute Its Covid-19 Vaccine
Success will hinge on an untested network of governments, companies and health workers.
0
What the Pfizer Vaccine Means for the Fight Against the Coronavirus?
A major advance in the race to develop a coronavirus shot has raised hopes that mass immunization could bring an end to the pandemic.
0
Five Questions to Ask About Pfizer’s Covid-19 Vaccine
Important scientific announcements are usually made through peer-reviewed medical research papers, not company press releases.
0
The Husband-and-Wife Team Behind the Leading Vaccine to Solve Covid-19
The German company BioNTech, founded by two scientists, has teamed up with Pfizer on a vaccine that was found to be more than 90 percent effective.
0
Don’t Get Too Excited About the Coronavirus Vaccine
It’s unmitigated good news. But it would be a tragic mistake to relax our vigilance right away.
0
A Collective Sigh of Relief Pushes the Stock Market Up
News of Pfizer’s Covid-19 vaccine progress, and Joseph R. Biden Jr.’s victory, gave investors reason to cheer.
0
The Pfizer Covid-19 Vaccine, Explained
What’s the big deal? Was it part of Operation Warp Speed? When can you get one?
0
Pfizer’s Early Data Shows Vaccine Is More Than 90% Effective
Pfizer announced stunning early results from its coronavirus vaccine trial, cementing the lead in a frenzied global race that has unfolded at record-breaking speed.
0
The Stressful Conclusion of a Clinical Trial
Does a pharmaceutical company have a moral obligation to acknowledge my participation with an ongoing supply of the product that I helped test?
0
Pfizer CEO All but Rules Out Covid-19 Vaccine Before Election Day
Pfizer’s C.E.O. said on Tuesday that much-anticipated results from its vaccine trial would not be coming this month, after all.
0
Coronavirus Vaccine: Pfizer Says It Won’t Seek Authorization Before Mid-November
Friday’s announcement represents a shift in tone for the company and its leader, who has repeatedly emphasized the month of October in interviews and public appearances.
0
Covid-19 Vaccines Offer Drug Makers Chance at Salvation, Financial and Beyond
Big profits beckon for pharmaceutical companies, which are already using their work on vaccines to fight efforts in Washington to curb drug prices.
0
Will Pfizer’s Vaccine Be Ready in October? Here’s Why That’s Unlikely.
Despite slim chances that its vaccine will be ready by October, Pfizer has big incentives to hint that it might be.
0
Novavax Enters Final Stage of Coronavirus Vaccine Trials
The Maryland company, which has never brought a vaccine to market, has started its Phase 3 trial in the United Kingdom, with plans to begin in the United States in October.
0
Johnson & Johnson Begins Phase 3 Trial of Covid-19 Vaccine
Unlike some of its competitors, Johnson & Johnson’s vaccine does not need to be frozen and may require just one shot instead of two.
0
Coronavirus Vaccine Trials Could Suffer From Shortcuts
We may not find out whether the vaccines prevent moderate or severe cases of Covid-19.
0
How to Ship a Vaccine at –80°C, and Other Obstacles in the Covid Fight
Developing an effective vaccine is the first step. Then comes the question of how to deliver hundreds of millions of doses that may need to be kept at arctic temperatures.
0
When Will You Be Able to Get a Coronavirus Vaccine?
Despite the president’s repeated claims that a vaccine will be available in October, scientists, companies and federal officials all say that most people won’t get one until well into next year.
0
Vaccine Makers Keep Safety Details Quiet, Alarming Scientists
Researchers say drug companies need to be more open about how vaccine trials are run to reassure Americans who are skittish about getting a coronavirus vaccine.
0
AstraZeneca Partly Resumes Coronavirus Vaccine Trial After Halting It for Safety
The company said tests of its vaccine would start up again in Britain while remaining suspended in the U.S. and other countries. Pfizer, a competitor, announced an expansion of its trials.
0
Pharma Companies Plan Joint Pledge on Vaccine Safety
The statement is meant to reassure the public that the companies will not seek a premature approval of vaccines under pressure from the Trump administration.
0
What We Know About the C.D.C.’s Covid-19 Vaccine Plans
The agency told public health agencies that two unidentified vaccines might be ready by October or November. We explain how vaccine trials work, when one might be ready, and who may get them first.
0
Coronavirus Crisis Has Made Brazil an Ideal Vaccine Laboratory
Widespread contagion, a deep bench of scientists and a robust vaccine-making infrastructure have made Brazil an important player in the quest to find a vaccine.
0
Pfizer Gets $1.95 Billion to Produce Coronavirus Vaccine by Year’s End
Two pharmaceutical companies announced a nearly $2 billion contract for 600 million doses of a vaccine, with the first 100 million promised before the end of the year.
0
Why It’s Unusual That The U.S. Committed to Buying Millions of Coronavirus Vaccine Doses
Besides the fact that there’s no coronavirus vaccine yet, the government usually lets the private sector handle it.
0
Three Coronavirus Vaccine Developers Report Promising Initial Results
Early trials showed a good immune response in vaccinated subjects, but one researcher sounded a note of caution: “There is still a long way to go.”
0
Trump Narrows Search for Coronavirus Vaccine to Five Firms
The White House is eager to project progress, but the public-private partnership it has created still faces scientific hurdles, internal tensions and questions from Congress.
0
Pfizer Begins Human Trials of Possible Coronavirus Vaccine
The drug company, along with a German partner, is running tests in healthy volunteers. It’s one of several companies on an accelerated timetable to try to find a safe, effective vaccine.
0